Reconstitution and syringe units

GHK-Cu Calculator

Convert a GHK-Cu (copper peptide) vial, the water added and an amount into units on a U-100 syringe.

Last updated Math checked by 520,000+ automated tests

GHK-Cu calculator

Example values are loaded. Replace them with the numbers on your own vial.

mg
mL
Syringe size
U-100 syringe: 100 units = 1 mLHow this is tested

Injectable GHK-Cu is not an approved medicine. The FDA has named it among the peptides it plans to review for pharmacy compounding before early 2027. Amounts below show the arithmetic only.

What GHK-Cu is

GHK-Cu is a small copper-binding peptide made of three amino acids (glycine, histidine and lysine) bound to a copper ion. It occurs naturally in human plasma and has a long history as an ingredient in topical skin-care products. Injectable forms are sold in larger vials than most peptides, commonly 50 mg or 100 mg, and reconstituted solutions are typically blue from the copper.

Units chart: 50 mg vial with 5 mL water

At 10 mg/mL, each unit on a U-100 syringe holds 0.1 mg (100 mcg).

Doses in this table show the arithmetic only. They are not recommendations.
DoseUnits (U-100)mL
500 mcg50.05
1 mg100.1
1.5 mg150.15
2 mg200.2
3 mg300.3
5 mg500.5

Units chart: 100 mg vial with 5 mL water

Doses in this table show the arithmetic only. They are not recommendations.
DoseUnits (U-100)mL
500 mcg2.50.025
1 mg50.05
1.5 mg7.50.075
2 mg100.1
3 mg150.15
5 mg250.25

Large vials and the use window

A 50 mg or 100 mg vial holds many small doses, and a punctured multi-dose vial usually has a limited use window, often 28 days. The vial supply calculator shows whether a vial will be finished inside that window.

Frequently asked questions

How many units is 1 mg of GHK-Cu?

In a 50 mg vial with 5 mL of water (10 mg/mL), 1 mg is 10 units. In a 100 mg vial with 5 mL (20 mg/mL), it is 5 units.

Why is GHK-Cu solution blue?

The peptide is bound to a copper ion, and copper complexes in solution are blue.

Related calculators and guides

Sources

  1. FDA signals potentially evolving stance toward compounding of certain peptides (Goodwin, May 2026)